BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 27797781)

  • 1. tcpl: the ToxCast pipeline for high-throughput screening data.
    Filer DL; Kothiya P; Setzer RW; Judson RS; Martin MT
    Bioinformatics; 2017 Feb; 33(4):618-620. PubMed ID: 27797781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. tcplfit2: an R-language general purpose concentration-response modeling package.
    Sheffield T; Brown J; Davidson S; Friedman KP; Judson R
    Bioinformatics; 2022 Jan; 38(4):1157-1158. PubMed ID: 34791027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ToxCast pipeline: updates to curve-fitting approaches and database structure.
    Feshuk M; Kolaczkowski L; Dunham K; Davidson-Fritz SE; Carstens KE; Brown J; Judson RS; Paul Friedman K
    Front Toxicol; 2023; 5():1275980. PubMed ID: 37808181
    [No Abstract]   [Full Text] [Related]  

  • 4. Incorporating High-Throughput Exposure Predictions With Dosimetry-Adjusted In Vitro Bioactivity to Inform Chemical Toxicity Testing.
    Wetmore BA; Wambaugh JF; Allen B; Ferguson SS; Sochaski MA; Setzer RW; Houck KA; Strope CL; Cantwell K; Judson RS; LeCluyse E; Clewell HJ; Thomas RS; Andersen ME
    Toxicol Sci; 2015 Nov; 148(1):121-36. PubMed ID: 26251325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hierarchical dose-response modeling for high-throughput toxicity screening of environmental chemicals.
    Wilson A; Reif DM; Reich BJ
    Biometrics; 2014 Mar; 70(1):237-46. PubMed ID: 24397816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of Pfizer compounds in EPA's ToxCast chemicals-assay space.
    Shah F; Greene N
    Chem Res Toxicol; 2014 Jan; 27(1):86-98. PubMed ID: 24328225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-throughput assay development for combined in vitro toxicity screening of hit compounds and their metabolites in early drug-discovery stage.
    Siricilla S
    Bioanalysis; 2017 Jul; 9(13):959-961. PubMed ID: 28708435
    [No Abstract]   [Full Text] [Related]  

  • 8. QSAR modeling of imbalanced high-throughput screening data in PubChem.
    Zakharov AV; Peach ML; Sitzmann M; Nicklaus MC
    J Chem Inf Model; 2014 Mar; 54(3):705-12. PubMed ID: 24524735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-Throughput Cell Toxicity Assays.
    Murray D; McWilliams L; Wigglesworth M
    Methods Mol Biol; 2016; 1439():245-62. PubMed ID: 27317000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integration of dosimetry, exposure, and high-throughput screening data in chemical toxicity assessment.
    Wetmore BA; Wambaugh JF; Ferguson SS; Sochaski MA; Rotroff DM; Freeman K; Clewell HJ; Dix DJ; Andersen ME; Houck KA; Allen B; Judson RS; Singh R; Kavlock RJ; Richard AM; Thomas RS
    Toxicol Sci; 2012 Jan; 125(1):157-74. PubMed ID: 21948869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of food-relevant chemicals in the ToxCast high-throughput screening program.
    Karmaus AL; Filer DL; Martin MT; Houck KA
    Food Chem Toxicol; 2016 Jun; 92():188-96. PubMed ID: 27103583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bayesian additive adaptive basis tensor product models for modeling high dimensional surfaces: an application to high-throughput toxicity testing.
    Wheeler MW
    Biometrics; 2019 Mar; 75(1):193-201. PubMed ID: 30081432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incorporating population variability and susceptible subpopulations into dosimetry for high-throughput toxicity testing.
    Wetmore BA; Allen B; Clewell HJ; Parker T; Wambaugh JF; Almond LM; Sochaski MA; Thomas RS
    Toxicol Sci; 2014 Nov; 142(1):210-24. PubMed ID: 25145659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-Content Assay Multiplexing for Toxicity Screening in Induced Pluripotent Stem Cell-Derived Cardiomyocytes and Hepatocytes.
    Grimm FA; Iwata Y; Sirenko O; Bittner M; Rusyn I
    Assay Drug Dev Technol; 2015 Nov; 13(9):529-46. PubMed ID: 26539751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation and calibration of high-throughput predictions of chemical distribution to tissues.
    Pearce RG; Setzer RW; Davis JL; Wambaugh JF
    J Pharmacokinet Pharmacodyn; 2017 Dec; 44(6):549-565. PubMed ID: 29032447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toward fully automated high performance computing drug discovery: a massively parallel virtual screening pipeline for docking and molecular mechanics/generalized Born surface area rescoring to improve enrichment.
    Zhang X; Wong SE; Lightstone FC
    J Chem Inf Model; 2014 Jan; 54(1):324-37. PubMed ID: 24358939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of normalization methods on high-throughput screening data with high hit rates and drug testing with dose-response data.
    Mpindi JP; Swapnil P; Dmitrii B; Jani S; Saeed K; Wennerberg K; Aittokallio T; Östling P; Kallioniemi O
    Bioinformatics; 2015 Dec; 31(23):3815-21. PubMed ID: 26254433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiating Pathway-Specific From Nonspecific Effects in High-Throughput Toxicity Data: A Foundation for Prioritizing Adverse Outcome Pathway Development.
    Fay KA; Villeneuve DL; Swintek J; Edwards SW; Nelms MD; Blackwell BR; Ankley GT
    Toxicol Sci; 2018 Jun; 163(2):500-515. PubMed ID: 29529260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computational toxicology as implemented by the U.S. EPA: providing high throughput decision support tools for screening and assessing chemical exposure, hazard and risk.
    Kavlock R; Dix D
    J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):197-217. PubMed ID: 20574897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-throughput analysis of behavior for drug discovery.
    Alexandrov V; Brunner D; Hanania T; Leahy E
    Eur J Pharmacol; 2015 Mar; 750():82-9. PubMed ID: 25592319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.